Dieter Ory1, Andrey Postnov2, Michel Koole2, Sofie Celen1, Bart de Laat2, Alfons Verbruggen1, Koen Van Laere2, Guy Bormans3, Cindy Casteels2. 1. Laboratory for Radiopharmacy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Campus Gasthuisberg O&N2, Herestraat 49 Box 821, BE-3000, Leuven, Belgium. 2. Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospital and KU Leuven, Leuven, Belgium. 3. Laboratory for Radiopharmacy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Campus Gasthuisberg O&N2, Herestraat 49 Box 821, BE-3000, Leuven, Belgium. Guy.Bormans@pharm.kuleuven.be.
Abstract
PURPOSE: [(18)F]DPA-714 is a radiotracer with high affinity for TSPO. We have characterized the kinetics of [(18)F]DPA-714 in rat brain and evaluated its ability to quantify TSPO expression with PET using a neuroinflammation model induced by unilateral intracerebral injection of lipopolysaccharide (LPS). METHODS: Dynamic small-animal PET scans with [(18)F]DPA-714 were performed in Wistar rats on a FOCUS-220 system for up to 3 h. Both plasma and perfused brain homogenates were analysed using HPLC to quantify radiometabolites. Full kinetic modelling of [(18)F]DPA-714 brain uptake was performed using a metabolite-corrected arterial plasma input function. Binding potential (BPND) calculated as the distribution volume ratio minus one (DVR-1) between affected and healthy brain tissue was used as the outcome measure and evaluated against reference tissue models. RESULTS: The percentage of intact [(18)F]DPA-714 in arterial plasma samples was 92 ± 4 % at 10 min, 75 ± 8 % at 40 min and 52 ± 6 % at 180 min. The radiometabolite fraction in brain was negligible (<3 % at 30 min). Among the models investigated, the reversible two-tissue (2T) compartment model best described [(18)F]DPA-714 brain kinetics. BPND values obtained with a simplified and a multilinear reference tissue model (SRTM, MRTM) using the contralateral striatum as the reference region correlated well (Spearman's r = 0.96, p ≤ 0.003) with 2T BPND values calculated as DVR-1, and showed comparable bias (bias range 17.94 %, 20.32 %). Analysis of stability over time suggested that the acquisition time should be at least 90 min for SRTM and MRTM. CONCLUSION: Quantification of [(18)F]DPA-714 binding to TSPO with full kinetic modelling is feasible using a 2T model. SRTM and MRTM can be suggested as reasonable substitutes with the contralateral striatum as the reference region and a scan duration of at least 90 min. However, selection of the reference region depends on the disease model used.
PURPOSE: [(18)F]DPA-714 is a radiotracer with high affinity for TSPO. We have characterized the kinetics of [(18)F]DPA-714 in rat brain and evaluated its ability to quantify TSPO expression with PET using a neuroinflammation model induced by unilateral intracerebral injection of lipopolysaccharide (LPS). METHODS: Dynamic small-animal PET scans with [(18)F]DPA-714 were performed in Wistar rats on a FOCUS-220 system for up to 3 h. Both plasma and perfused brain homogenates were analysed using HPLC to quantify radiometabolites. Full kinetic modelling of [(18)F]DPA-714 brain uptake was performed using a metabolite-corrected arterial plasma input function. Binding potential (BPND) calculated as the distribution volume ratio minus one (DVR-1) between affected and healthy brain tissue was used as the outcome measure and evaluated against reference tissue models. RESULTS: The percentage of intact [(18)F]DPA-714 in arterial plasma samples was 92 ± 4 % at 10 min, 75 ± 8 % at 40 min and 52 ± 6 % at 180 min. The radiometabolite fraction in brain was negligible (<3 % at 30 min). Among the models investigated, the reversible two-tissue (2T) compartment model best described [(18)F]DPA-714 brain kinetics. BPND values obtained with a simplified and a multilinear reference tissue model (SRTM, MRTM) using the contralateral striatum as the reference region correlated well (Spearman's r = 0.96, p ≤ 0.003) with 2T BPND values calculated as DVR-1, and showed comparable bias (bias range 17.94 %, 20.32 %). Analysis of stability over time suggested that the acquisition time should be at least 90 min for SRTM and MRTM. CONCLUSION: Quantification of [(18)F]DPA-714 binding to TSPO with full kinetic modelling is feasible using a 2T model. SRTM and MRTM can be suggested as reasonable substitutes with the contralateral striatum as the reference region and a scan duration of at least 90 min. However, selection of the reference region depends on the disease model used.
Authors: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2007-05-09 Impact factor: 6.200
Authors: Ling Feng; Claus Svarer; Gerda Thomsen; Robin de Nijs; Vibeke A Larsen; Per Jensen; Dea Adamsen; Agnete Dyssegaard; Walter Fischer; Per Meden; Derk Krieger; Kirsten Møller; Gitte M Knudsen; Lars H Pinborg Journal: J Nucl Med Date: 2014-11-13 Impact factor: 10.057
Authors: Cindy Casteels; Peter Vermaelen; Johan Nuyts; Annemie Van Der Linden; Veerle Baekelandt; Luc Mortelmans; Guy Bormans; Koen Van Laere Journal: J Nucl Med Date: 2006-11 Impact factor: 10.057
Authors: Hervé Boutin; Christian Prenant; Renaud Maroy; James Galea; Andrew D Greenhalgh; Alison Smigova; Christopher Cawthorne; Peter Julyan; Shane M Wilkinson; Samuel D Banister; Gavin Brown; Karl Herholz; Michael Kassiou; Nancy J Rothwell Journal: PLoS One Date: 2013-02-13 Impact factor: 3.240
Authors: Anindya Bhattacharya; Noel C Derecki; Timothy W Lovenberg; Wayne C Drevets Journal: Psychopharmacology (Berl) Date: 2016-01-23 Impact factor: 4.530
Authors: Donatienne Van Weehaeghe; Evelien Van Schoor; Joke De Vocht; Michel Koole; Bala Attili; Sofie Celen; Lieven Declercq; Dietmar R Thal; Philip Van Damme; Guy Bormans; Koen Van Laere Journal: J Nucl Med Date: 2019-09-27 Impact factor: 11.082
Authors: Lingling Zhang; Kuan Hu; Tuo Shao; Lu Hou; Shaojuan Zhang; Weijian Ye; Lee Josephson; Jeffrey H Meyer; Ming-Rong Zhang; Neil Vasdev; Jinghao Wang; Hao Xu; Lu Wang; Steven H Liang Journal: Acta Pharm Sin B Date: 2020-08-25 Impact factor: 11.413